ARCHIVES

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

This article is from The Cancer Letter archive.

Vol. 27 No. 3 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

DeVita To continue Discussions On Expanded Chops Despite ACCC Coolness; Would Go To DRCCA Board

March 27, 1981